We have located links that may give you full text access.
Power of Three: Incremental Increase in the Ligand Field Strength of N-Alkylated 2,2'-Biimidazoles Leads to Spin Crossover in Homoleptic Tris-Chelated Fe(II) Complexes.
Inorganic Chemistry 2018 May 8
Homoleptic complexes [Fe(L n )]X2 (L1 = 1,1'-(α,α'- o-xylyl)-2,2'-biimidazole, L2 = 1,1'-(α,α'-3,4-dibromo- o-xylyl)-2,2'-biimidazole, L3 = 1,1'-(α,α'-2,5-dimethoxy- o-xylyl)-2,2'-biimidazole; X = BF4 - or ClO4 - ) were synthesized by direct reactions of the Fe(II) precursor salts and bidentate ligands L1 , L2 , or L3 . All mononuclear complexes undergo gradual temperature-driven spin-crossover (SCO) between the high-spin (HS, S = 2) and low-spin (LS, S = 0) states. Complexes with ligands L1 and L2 synthesized in methanol exhibit complete SCO with the midpoint of the LS↔HS conversion varying from 233 to 313 K, while complexes with ligand L3 , crystallized from an ethanol/dichloromethane mixture, exhibit incomplete SCO with the residual HS/LS ratio of ∼1:4 for [Fe(L3 )3 ](BF4 )2 and ∼1:1 for [Fe(L3 )3 ](ClO4 )2 . Complexes with L1 can also be recrystallized from ethanol/dichloromethane, in which case they exhibit very gradual and incomplete SCO, similar to those of the complexes with L3 . The differences in magnetic behavior have been traced back to peculiarities of molecular packing observed in the corresponding crystal structures. Density-functional theoretical calculations provide justification to the SCO behavior of these complexes, as compared to the HS-only behavior observed for the parent [Fe(bim)3 ]2+ complex with nonalkylated 2,2'-biimidazole (bim).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app